Liminatus Pharma, Inc. Class A Common Stock (LIMN)
NASDAQ·Healthcare·Biotechnology
$0.20
-1.78%
Mkt Cap $6.34M
Mkt Cap
$6.34M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.91
NASDAQ·Healthcare·Biotechnology
$0.20
-1.78%
Mkt Cap $6.34M
Mkt Cap
$6.34M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.91